Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment

Background: Circulating tumor DNA (ctDNA) released from tumor cells carries the tumor-associated genetic and epigenetic characteristics of cancer patients. Next-generation sequencing (NGS) facilitates the application of ctDNA profiling for identification and monitoring of minimal residual disease (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Linghui, Zhao, Houli, Shao, Yang, Chen, Xin, Hong, Ruimin, Wang, Linqin, Ni, Fang, Nagler, Arnon, Hu, Yongxian, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364638/
https://www.ncbi.nlm.nih.gov/pubmed/34405005
http://dx.doi.org/10.7150/jca.60390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364638/
https://www.ncbi.nlm.nih.gov/pubmed/34405005
http://dx.doi.org/10.7150/jca.60390

Ejemplares similares